Mechanisms of Glucocorticoid-Induced Insulin Resistance Focus on Adipose Tissue Function and Lipid Metabolism

被引:275
作者
Geer, Eliza B. [1 ]
Islam, Julie [2 ]
Buettner, Christoph [1 ]
机构
[1] Mt Sinai Med Ctr, Div Endocrinol, New York, NY 10029 USA
[2] Beth Israel Deaconess Med Ctr, Div Endocrinol & Metab, New York, NY 10003 USA
关键词
Glucocorticoids; Cushing syndrome; Adipose tissue; Lipolysis; Lipids; Insulin resistance; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; PITUITARY-ADRENAL AXIS; BODY-FAT DISTRIBUTION; TUMOR-NECROSIS-FACTOR; DE-NOVO LIPOGENESIS; MAGNETIC-RESONANCE-SPECTROSCOPY; NONALCOHOLIC HEPATIC STEATOSIS; SPLANCHNIC CORTISOL PRODUCTION; ENDOGENOUS CUSHINGS-SYNDROME; HORMONE-SENSITIVE LIPASE;
D O I
10.1016/j.ecl.2013.10.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoids (GCs) are critical in the regulation of the stress response, inflammation and energy homeostasis. Excessive GC exposure results in whole-body insulin resistance, obesity, cardiovascular disease, and ultimately decreased survival, despite their potent anti-inflammatory effects. This apparent paradox may be explained by the complex actions of GCs on adipose tissue functionality. The wide prevalence of oral GC therapy makes their adverse systemic effects an important yet incompletely understood clinical problem. This article reviews the mechanisms by which supraphysiologic GC exposure promotes insulin resistance, focusing in particular on the effects on adipose tissue function and lipid metabolism.
引用
收藏
页码:75 / +
页数:29
相关论文
共 215 条
  • [21] ACTH 1-24 DECREASES HEPATIC LIPASE ACTIVITIES AND LOW-DENSITY-LIPOPROTEIN CONCENTRATIONS IN HEALTHY-MEN
    BERG, AL
    HANSSON, P
    NILSSONEHLE, P
    [J]. JOURNAL OF INTERNAL MEDICINE, 1991, 229 (02) : 201 - 203
  • [22] ACTH lowers serum lipids in steroid-treated hyperlipemic patients with kidney disease
    Berg, AL
    NilssonEhle, P
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (02) : 538 - 542
  • [23] DIRECT EFFECTS OF CORTICOTROPIN ON PLASMA-LIPOPROTEIN METABOLISM IN MAN - STUDIES IN-VIVO AND IN-VITRO
    BERG, AL
    NILSSONEHLE, P
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (01): : 90 - 97
  • [24] Additive action of 11β-HSD1 inhibition and PPAR-γ agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats
    Berthiaume, M.
    Laplante, M.
    Festuccia, W. T.
    Berger, J. P.
    Thieringer, R.
    Deshaies, Y.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2009, 33 (05) : 601 - 604
  • [25] 11β-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues
    Berthiaume, Magalie
    Laplante, Mathieu
    Festuccia, William T.
    Cianflone, Katherine
    Turcotte, Lorraine P.
    Joanisse, Denis R.
    Olivecrona, Gunilla
    Thieringer, Rolf
    Deshaies, Yves
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 293 (04): : E1045 - E1052
  • [26] Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11β-hydroxysteroid dehydrogenase type 1
    Berthiaume, Magalie
    Laplante, Mathieu
    Festuccia, William
    Gelinas, Yves
    Poulin, Sebastien
    Lalonde, Josee
    Joanisse, Denis R.
    Thieringer, Rolf
    Deshaies, Yves
    [J]. ENDOCRINOLOGY, 2007, 148 (05) : 2391 - 2397
  • [27] Expression of 11-Hydroxysteroid Dehydrogenase Type 1 in the Human Hypothalamus
    Bisschop, P. H.
    Dekker, M. J. H. J.
    Osterthun, W.
    Kwakkel, J.
    Anink, J. J.
    Boelen, A.
    Unmehopa, U. A.
    Koper, J. W.
    Lamberts, S. W. J.
    Stewart, P. M.
    Swaab, D. F.
    Fliers, E.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2013, 25 (05) : 425 - 432
  • [28] The role of TNF-α in insulin resistance
    Borst, SE
    [J]. ENDOCRINE, 2004, 23 (2-3) : 177 - 182
  • [29] Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue
    Bruun, JM
    Lihn, AS
    Madan, AK
    Pedersen, SB
    Schiott, KM
    Fain, JN
    Richelsen, B
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 286 (01): : E8 - E13
  • [30] A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
    Bujalska, I. J.
    Gathercole, L. L.
    Tomlinson, J. W.
    Darimont, C.
    Ermolieff, J.
    Fanjul, A. N.
    Rejto, P. A.
    Stewart, P. M.
    [J]. JOURNAL OF ENDOCRINOLOGY, 2008, 197 (02) : 297 - 307